Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 2
2015 3
2016 2
2017 5
2018 5
2020 2
2021 4
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Microbial nanotechnology: a new frontier in microbiology.
Verma ML, Joseph PJ, Sen Karaman D. Verma ML, et al. Among authors: sen karaman d. Front Microbiol. 2023 Oct 19;14:1296573. doi: 10.3389/fmicb.2023.1296573. eCollection 2023. Front Microbiol. 2023. PMID: 37928693 Free PMC article. No abstract available.
Editorial: Women in antimicrobials, resistance and chemotherapy: 2022.
Freitas AR, Karaman DŞ, Teh CSJ. Freitas AR, et al. Among authors: karaman ds. Front Microbiol. 2023 Feb 8;14:1148777. doi: 10.3389/fmicb.2023.1148777. eCollection 2023. Front Microbiol. 2023. PMID: 36846782 Free PMC article. No abstract available.
Solving the antibacterial resistance in Europe: The multipronged approach of the COST Action CA21145 EURESTOP.
Seguin-Devaux C, Mestrovic T, Arts JJ, Sen Karaman D, Nativi C, Reichmann D, Sahariah P, Smani Y, Rijo P, Mori M; COST Action CA21145 EURESTOP. Seguin-Devaux C, et al. Among authors: sen karaman d. Drug Resist Updat. 2024 May;74:101069. doi: 10.1016/j.drup.2024.101069. Epub 2024 Feb 17. Drug Resist Updat. 2024. PMID: 38458099 No abstract available.
Anti-bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates against resistant and non-resistant pathogens.
Pardhi DM, Şen Karaman D, Timonen J, Wu W, Zhang Q, Satija S, Mehta M, Charbe N, McCarron PA, Tambuwala MM, Bakshi HA, Negi P, Aljabali AA, Dua K, Chellappan DK, Behera A, Pathak K, Watharkar RB, Rautio J, Rosenholm JM. Pardhi DM, et al. Among authors: sen karaman d. Int J Pharm. 2020 Aug 30;586:119531. doi: 10.1016/j.ijpharm.2020.119531. Epub 2020 Jun 12. Int J Pharm. 2020. PMID: 32540348 Review.
Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems.
Sahlgren C, Meinander A, Zhang H, Cheng F, Preis M, Xu C, Salminen TA, Toivola D, Abankwa D, Rosling A, Karaman DŞ, Salo-Ahen OMH, Österbacka R, Eriksson JE, Willför S, Petre I, Peltonen J, Leino R, Johnson M, Rosenholm J, Sandler N. Sahlgren C, et al. Among authors: karaman ds. Adv Healthc Mater. 2017 Nov;6(21). doi: 10.1002/adhm.201700258. Epub 2017 Sep 11. Adv Healthc Mater. 2017. PMID: 28892296 Review.
Comparative safety evaluation of silica-based particles.
Kettiger H, Sen Karaman D, Schiesser L, Rosenholm JM, Huwyler J. Kettiger H, et al. Among authors: sen karaman d. Toxicol In Vitro. 2015 Dec 25;30(1 Pt B):355-63. doi: 10.1016/j.tiv.2015.09.030. Epub 2015 Oct 3. Toxicol In Vitro. 2015. PMID: 26434530
28 results